Internet-Based Intervention for Young Breast Cancer Survivors
(YES Trial)
Trial Summary
What is the purpose of this trial?
This clinical trial compares a web-based patient-reported symptom monitoring and self management portal, the Young, Empowered \& Strong (YES), to standard therapy in managing symptoms in adolescent and young adult breast cancer survivors. YES is a web-based portal (website) to help monitor issues or symptoms women with breast cancer may experience. The YES portal may improve the quality of life of young breast cancer survivors. The YES portal may help manage symptoms and provide useful information/resources.
Do I have to stop taking my current medications for this trial?
The trial protocol does not specify whether you need to stop taking your current medications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on using a web-based portal to manage symptoms, so it's likely you can continue your current treatments, but you should confirm with the study team.
What data supports the idea that Internet-Based Intervention for Young Breast Cancer Survivors is an effective treatment?
The available research shows that the Internet-Based Intervention for Young Breast Cancer Survivors, like the Sharsheret's Thriving Again program, is effective because most participants found it helpful. Specifically, 94% of women said it helped with cancer treatment, 85% with follow-up, and 91% with discussions with their doctors. Additionally, 75% of women were satisfied with the timing of receiving the support kit. This suggests that the program is beneficial in providing timely and useful support to young breast cancer survivors.12345
What data supports the effectiveness of the Internet-Based Intervention for Young Breast Cancer Survivors treatment?
The evaluation of Sharsheret's Thriving Again program, which is similar to the YES Portal, showed that most young breast cancer survivors found the survivorship care plan helpful for managing treatment and follow-up, with 94% finding it facilitated cancer treatment and 85% finding it useful for follow-up. This suggests that internet-based interventions can be beneficial for young breast cancer survivors.12345
What safety data exists for the Internet-Based Intervention for Young Breast Cancer Survivors?
The provided research does not directly address safety data for the Internet-Based Intervention for Young Breast Cancer Survivors, including the YES Portal. The studies focus on survivorship care planning, fertility issues, program evaluations, and rehabilitation for young breast cancer survivors, but do not specifically mention safety data for the YES intervention or similar programs.12678
Is the Internet-Based Intervention a promising treatment for young breast cancer survivors?
How does the Internet-Based Intervention for Young Breast Cancer Survivors differ from other treatments?
Research Team
Michelle Naughton, PhD
Principal Investigator
Ohio State University Comprehensive Cancer Center
Eligibility Criteria
This trial is for young female breast cancer survivors aged 15-39, within 3 years of a stage 0-III diagnosis. They must be free from recurrence or new cancers (except non-melanoma skin cancer), able to understand English, access their medical records, and willing to use email/text for communication.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive access to the YES portal or usual care for 9 months, with surveys completed at baseline and 3, 6, and 9 months
Follow-up
Participants are monitored for sustainability of effects on quality of life and symptoms after the 6-month intervention period
Open-label extension (optional)
Participants in the usual care group may receive access to the YES portal for an additional 3 months
Treatment Details
Interventions
- Young, Empowered & Strong (YES)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ohio State University Comprehensive Cancer Center
Lead Sponsor
Dana-Farber Cancer Institute
Collaborator
Columbia University
Collaborator
National Cancer Institute (NCI)
Collaborator